However, our in vitro study (using MTS and BrdU assays and cell cycle analysis) clearly confirmed the antiproliferative activity of EOT in estrogen receptor (ER)-positive and ER-negative breast adenocarcinoma cell lines, which is consistent with the results of other authors [50]. This evidence concerns the gene ESR1 and breast adenocarcinoma.